Is United Therapeutics Corp. UTHR stock Halal to invest in?

Yes, as of September 2026, United Therapeutics Corp. stock (UTHR) is classified as a Shariah compliant stock. Tabadulat applies AAOIFI Shariah Standard No. 21, issued by the Accounting and Auditing Organization for Islamic Financial Institutions, screening non-permissible income first and then the two interest-based ratios and the capital structure. On the latest data, United Therapeutics Corp. passes on every count: non-permissible income under 5% of revenue, interest-bearing debt and investments each under 30% of market capitalisation, and no preference share issue. The stock's current purification factor is 96.2%. Compliance is reassessed every month as updated screening data arrives, and a stock's status can change when new financial reports are released. You can always check the current status of United Therapeutics Corp. and explore other Shariah compliant stocks in the Tabadulat app.

How often is United Therapeutics Corp. UTHR reviewed for Shariah compliance?

Tabadulat reviews United Therapeutics Corp. UTHR for Shariah compliance every month. Each review applies the AAOIFI Shariah Standard No. 21 methodology, screening the company's business activities, non-permissible income, interest-bearing investments, interest-bearing debt, and preference shares, against the company's latest available financial data. The process operates under the direct supervision of Tabadulat's dedicated Shariah Supervisory Board of Islamic finance scholars. Because compliance depends on financial ratios that move with market capitalisation and reported results, a stock's status can change from one review to the next. Monthly screening ensures the status shown for United Therapeutics Corp. reflects current financial data rather than an outdated assessment, and Tabadulat app users are notified if a holding in their portfolio becomes non-compliant.

Does United Therapeutics Corp. UTHR pass the AAOIFI Non Permissible Income criteria?

Yes, as of September 2026, United Therapeutics Corp. stock (UTHR) passes the AAOIFI non-permissible income screen. Under AAOIFI Shariah Standard No. 21, income from impermissible sources (such as interest or Riba, conventional financial services, alcohol, gambling, or tobacco) must remain below 5% of a company's total revenue. United Therapeutics Corp.'s income from non-permissible sources is currently within this 5% threshold. Even permissible levels of incidental impure income should still be purified: investors donate the corresponding share of dividends to charity, as reflected in the stock's purification factor. This screen is reassessed monthly using the company's latest financial disclosures.

Does United Therapeutics Corp. UTHR pass the AAOIFI Interest Bearing Investments criteria?

Yes, as of September 2026, United Therapeutics Corp. stock (UTHR) passes the AAOIFI interest-bearing investments screen. Each month Tabadulat compares United Therapeutics Corp.'s holdings in interest-earning instruments, such as conventional deposits, bonds and treasury bills, against AAOIFI's 30% market capitalisation cap. The current screening shows the company inside the limit. Because the ratio is measured against market capitalisation, it can move with the share price as well as the balance sheet, which is why Tabadulat rescreens the stock every month.

Does United Therapeutics Corp. UTHR pass the AAOIFI Interest Bearing Debt criteria?

Yes, as of September 2026, United Therapeutics Corp. stock (UTHR) passes the AAOIFI interest-bearing debt screen. AAOIFI tolerates some conventional borrowing but draws the line at 30% of market capitalisation. On the latest data, United Therapeutics Corp.'s interest-bearing debt stays below the line. Because market capitalisation changes daily, a company's debt ratio can drift toward or away from the limit even without new borrowing, which is why this screen is reassessed every month.

What is the dividend purification factor for United Therapeutics Corp. UTHR stock?

The dividend purification factor for United Therapeutics Corp. (UTHR) stands at 96.2% in the September 2026 screening. In plain terms, 96.2% of a UTHR dividend is retained, and the remainder reflects incidental non-permissible income, typically interest on corporate cash, which Halal investors donate to charity (Tazkiyah). AAOIFI methodology asks for purification even on fully compliant stocks. The factor is recalculated with each monthly screening as new financial data arrives, and the Tabadulat app can help you calculate and track purification across your whole portfolio.

Does United Therapeutics Corp. UTHR pass the AAOIFI Preference Share screen?

Yes, as of September 2026, United Therapeutics Corp. stock (UTHR) passes the AAOIFI preference share screen. AAOIFI Shariah Standard No. 21 prohibits investing in preference shares because they grant holders guaranteed or priority rights to dividends and capital ahead of ordinary shareholders, a structure that conflicts with the Shariah principle that investors should share profit and loss in proportion to their ownership. United Therapeutics Corp. has no impermissible preference share structure affecting its ordinary shares, so the stock is compliant on this criterion. Like all AAOIFI screens, this is verified in each monthly review.

Invest Halal, Anytime, Anywhere

Download the Tabadulat app and start building your Shariah-compliant portfolio in minutes.

English

العربية

Is United Therapeutics (UTHR) stock Halal?

NASDAQ

Shariah-Compliant

Not Shariah

September 2026 AAOIFI screening result for United Therapeutics Corp. (UTHR): non-permissible income, pass. Interest-bearing investments, pass. Interest-bearing debt, pass. Preference shares, pass. Dividend purification factor: 96.2%. Re-screened monthly against AAOIFI Shariah Standard No. 21.

Sector:

Healthcare

Industry:

Drug Manufacturers - Specialty & Generic

Employees:

1305

Website:

https://www.unither.com

Market cap:

$21.1B

P/E ratio:

18.4

Dividend yield:

52-week range:

$375.61 - $609.35

Data as of:

3 September 2026

Screening history:

September 2026: PASS

United Therapeutics is a biotechnology company engaged in the development and commercialization of innovative pharmaceutical products. Primarily focusing on therapies to address unmet medical needs for chronic and life-threatening conditions, United Therapeutics is notable for its contributions in the field of pulmonary arterial hypertension (PAH). The company offers a portfolio of products that include both oral and inhaled treatments, such as Remodulin and Tyvaso, providing critical care solutions that significantly improve patients' quality of life. Before any of that matters to a Muslim investor, one question comes first: is United Therapeutics stock Halal?

Is United Therapeutics Shariah compliant?

Healthcare rarely troubles the activity screen; treating illness is permissible work. For United Therapeutics, the AAOIFI Shariah Standard No. 21 verdict turns on the balance sheet instead: research is capital hungry, and interest bearing debt and investments must each stay below 30% of market capitalisation.

Does United Therapeutics pass the business activity test?

Yes. In the September 2026 screening United Therapeutics holds an overall PASS, which a stock only earns when its core business clears the activity screen. Treating illness is permissible work; the scrutiny belongs to the financing behind it.

Is United Therapeutics' income Halal?

Yes, within AAOIFI's tolerance. United Therapeutics' income from non-permissible sources stays below 5% of revenue in the September 2026 screening, and the small impure portion is handled through purification: the factor of 96.2% tells holders of UTHR what share of each dividend to keep and what remainder to donate to charity.

Does United Therapeutics meet AAOIFI's debt and investment ratio requirements?

Yes. Both caps hold this month: interest bearing investments and interest bearing debt each stay below 30% of market capitalisation. Because the caps move with the share price, our Shariah Supervisory Board has UTHR re-screened every month, and the result above always shows the latest verdict.

Tabadulat is an ADGM regulated brokerage whose license covers Shari'a Compliant Regulated Activities, as the FSRA permission names them. New to the terminology? Gharar and Maysir, Sukuk, Zakat and purification are all explained in plain English.

New to the four screens? Read What is Halal Investing? A Guide to Halal Stocks and Islamic Finance

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Open your account.

Create your Tabadulat account in minutes: enter your details, complete identity verification, and add funds by secure transfer in multiple currencies. You're ready to start investing in Halal stocks the same day.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.